<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<doc>
  <docno>
    <textblock>FR940125-2-00006</textblock>
  </docno>
  <parent>
    <textblock>FR940125-2-00005</textblock>
  </parent>
  <text>
    <textblock>Nu Skin International, Inc., et al; Proposed Consent Agreement With Analysis To Aid Public Comment</textblock>
  </text>
  <usdept>
    <textblock>FEDERAL TRADE COMMISSION</textblock>
  </usdept>
  <rindock>
    <textblock>[File No. 912 3071]</textblock>
  </rindock>
  <agency>
    <textblock>AGENCY:</textblock>
    <textblock>Federal Trade Commission.</textblock>
  </agency>
  <action>
    <textblock>ACTION:</textblock>
    <textblock>Proposed consent agreement.</textblock>
  </action>
  <summary>
    <textblock>SUMMARY:</textblock>
    <textblock>In settlement of alleged violations of federal law prohibiting unfair acts and practices and unfair methods of competition, this consent agreement, accepted subject to final Commission approval, would prohibit, among other things, a Provo Utah-based multi-level marketing company and its principals from making deceptive claims about its purported baldness treatment, purported wrinkle lotion, purported burn cream, or substantially similar products, and require them to possess scientific evidence to substantiate a variety of product performance, benefits, efficacy, or safety claims for those and other products. The respondents would also be required to make certain disclosures in connection with future earnings claims to prospective distributors, and disgorge a total of $1.225 million.</textblock>
  </summary>
  <date>
    <textblock>DATES:</textblock>
    <textblock>Comments must be received on or before March 28, 1994.</textblock>
  </date>
  <address>
    <textblock>ADDRESSES:</textblock>
    <textblock>Comments should be directed to: FTC/Office of the Secretary, room 159, 6th St. and Pa. Ave., NW., Washington, DC 20580.</textblock>
  </address>
  <further>
    <textblock>FOR FURTHER INFORMATION CONTACT:</textblock>
    <textblock>C. Steven Baker or Nicholas J. Franczyk, Chicago Regional Office, Federal Trade Commission, 55 East Monroe Street, suite 1437, Chicago IL 60603, (312) 353-8156.</textblock>
  </further>
  <supplem>
    <textblock>SUPPLEMENTARY INFORMATION:</textblock>
    <textblock>Pursuant to Section 6(f) of the Federal Trade Commission Act, 38 Stat. 721, 15 U.S.C. 46 and ยง2.34 of the Commission's Rules of Practice (16 CFR 2.34), notice is hereby given that the following consent agreement containing a consent order to cease and desist, having been filed with and accepted, subject to final approval, by the Commission, has been placed on the public record for a period of sixty (60) days. Public comment is invited. Such comments or views will be considered by the Commission and will be available for inspection and copying at its principal office in accordance with ยง4.9(b)(6)(ii) of the Commission's Rules of Practice (16 CFR 4.9(b)(6)(ii)).</textblock>
    <textblock>In the Matter of Nu Skin International Inc., CJM, Inc., CST Management, Inc., and CK&amp;C, Inc., corporations, Clara McDermott, individually and as an officer and director of CJM, Inc., Craig Tillotson, individually and as an officer and director of CST Management, Inc., and Craig Bryson, individually and as an officer and director of CK&amp;C, Inc.</textblock>
    <textblock>Agreement Containing Consent Order To Cease and Desist</textblock>
  </supplem>
</doc>
